High-Dose Inhaled Nitric Oxide in Acute Hypoxemic Respiratory Failure Due to COVID-19: A Multicenter Phase II Trial is a research paper published in American Journal of Respiratory and Critical Care Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 46 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Foundation for the NIH
Grant: UM1AI069412
National Institutes of Health
Grant: 2UM1AI069412-08
Harvard/Boston/Providence Clinical Trials Unit (Harvard/B/P CTU)
Linde plc
University of Alabama at Birmingham
Danderyd Hospital
Massachusetts General Hospital
Louisiana State University Shreveport
Beth Israel Deaconess Medical Center
Mallinckrodt Pharmaceuticals
FWCI
7.84
Citation Percentile
1.0%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals